Redeye comments on Litium’s Q4, which showed solid momentum with 18% ARR growth and net sales above our expectations. While ARR came in slightly below our forecast, stronger-than-expected subscription and variable revenues suggest the deviation likely relates to Geins consolidation rather than underlying weakness. With record order intake and encouraging early signs from the Monitor ERP partnership, we like what we see.
LÄS MER
